Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Palatrigine (BW-A 256C) is a compound with angiotensin-converting enzyme inhibitory and beta-adrenergic receptor blocking properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 80.00 | |
5 mg | In stock | $ 180.00 | |
10 mg | In stock | $ 260.00 | |
25 mg | In stock | $ 506.00 | |
50 mg | In stock | $ 680.00 | |
100 mg | In stock | $ 968.00 | |
500 mg | In stock | $ 1,930.00 |
Description | Palatrigine (BW-A 256C) is a compound with angiotensin-converting enzyme inhibitory and beta-adrenergic receptor blocking properties. |
In vitro | BW A256C reduced the maximum rate of depolarization of guinea-pig ventricle and dog Purkinje fibres in vitro (EC50, 2.2 X 10(-6) M and 1.8 X 10(-6) M, respectively).[1] |
In vivo | In conscious dogs, BW A256C (1.5 mg/kg; intravenous infusion) or BW A256C (1.25-5 mg/kg;oral administration) caused dose-dependent suppression of the ventricular ectopic activity that occurred following 20-24 h of permanent coronary artery ligation.[1] |
Synonyms | BW-A 256C, BW A256C |
Molecular Weight | 298.17 |
Formula | C12H13Cl2N5 |
CAS No. | 98410-36-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (83.84 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Palatrigine 98410-36-7 GPCR/G Protein Metabolism Neuroscience Angiotensin-converting Enzyme (ACE) Adrenergic Receptor BW-A 256C BW A256C inhibitor inhibit